AR9.AX stock jumped 7.14% pre-market to A$0.09 after archTIS released its earnings update on 27 Feb 2026. The move lifted volume to 4,986,093 shares, well above the 741,995 average, signalling investor attention ahead of management commentary. archTIS (AR9.AX) reports an EPS of -0.02 and a trailing PE of -4.50, leaving valuation sensitive to guidance and contract wins in the secure collaboration market in Australia and overseas.
AR9.AX stock: Pre-market earnings reaction
archTIS (AR9.AX) moved from A$0.084 previous close to A$0.09 on heavy volume, a sign markets are pricing new earnings detail. The intraday range shows a Day Low A$0.086 and Day High A$0.10, with year range A$0.05–A$0.28, highlighting high volatility.
Earnings details and financials
The company reported an EPS of -0.02, reflecting continued operating losses despite positive cash flow metrics. archTIS shows operating cash flow per share A$0.01 and free cash flow per share A$0.01, which supports short-term liquidity even though the current ratio is 0.61.
Valuation and analyst view
Valuation metrics are mixed: price-to-sales 5.19, price-to-book 4.76, and a negative PE of -4.50. Market cap stands at A$31,489,810.00 with 349,886,777 shares outstanding, leaving per-share valuation sensitive to contract renewals and FY revenue growth.
Technical indicators and Meyka AI grade
Technicals show neutral momentum with RSI 48.52 and Bollinger middle at A$0.09. Relative volume is strong at 6.72x, which often precedes short-term directional moves.
Meyka AI rates AR9.AX with a score out of 100: 71.85 (B+) — Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Grades are model outputs and not financial advice.
Price forecast and outlook
Meyka AI’s forecast model projects a 12-month price of A$0.15, versus the current A$0.09, implying an upside of 65.00%. This projection uses revenue trends, cash flow resilience, and sector multiples, but forecasts are model-based projections and not guarantees.
Risks and opportunities for AR9.AX earnings
Key upside drivers are government and defence contract wins for Kojensi and stronger enterprise adoption of NC Protect, which would lift revenue per share above A$0.02. Major risks include thin liquidity, low current ratio, and continued negative net margins that could dilute share value under cash stress.
Final Thoughts
archTIS (AR9.AX) is trading pre-market at A$0.09 after its 27 Feb 2026 earnings release. The stock shows a volatile profile with heavy volume 4,986,093 and relative volume 6.72x, indicating active repositioning by traders. Fundamentals show negative EPS -0.02 and a negative PE -4.50, but operating and free cash flow per share of A$0.01 help reduce immediate liquidity pressure. Meyka AI’s forecast model projects A$0.15 in 12 months, an implied upside of 65.00% from today, while our pragmatic price targets place a near-term base at A$0.06, a conservative 12-month target at A$0.12, and a bull case at A$0.20 if contract momentum accelerates. Investors should balance the growth opportunity in secure collaboration software against execution risk and tight balance-sheet ratios. For active traders we note technical neutrality and close monitoring of contract announcements; for longer-term investors the mix of cash flow resilience and market opportunity supports a watchlist position. See the archTIS profile on Meyka for live tools and AI-powered market analysis and check comparisons at Investing.com for peer context.
FAQs
What is the short-term outlook for AR9.AX stock?
Short-term outlook is event-driven. The stock trades at A$0.09 with heavy volume; watch contract news and any management guidance. Technicals show neutral momentum, so moves will follow news or changes in liquidity.
How does archTIS report affect valuation metrics?
Earnings show EPS -0.02 and negative margins, which keep PE negative. Cash flow per share of A$0.01 supports liquidity, but valuation hinges on revenue growth and contract wins to improve price-to-sales and price-to-book ratios.
What are realistic price targets for AR9.AX?
A conservative near-term floor is A$0.06, a 12-month base target A$0.12, and a bull case A$0.20 if enterprise and government contracts scale. These targets assume successful execution and are not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)